Everest Medicines Secures Exclusive License for Sumecigrel in Asia-Pacific, Expanding Its Cardiovascular Product Portfolio

Everest Medicines Secures Exclusive License for Sumecigrel in Asia-Pacific, Expanding Its Cardiovascular Product Portfolio
Bacakan Artikel

Intens.id,

 Everest Medicines today announced that it has entered into an exclusive licensing agreement with Jiangsu Vcare ...